Access Bio Inc Cash Flow Quality Index
Access Bio Inc cash flow quality index. Access Bio Inc (950130) has a Cash Flow Quality Index of -6.44x as of June 2024. Operating cash flow of ₩-9.83 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. See Access Bio Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Access Bio Inc (2012–2022)
Cash flow quality index of Access Bio Inc from 2012 to 2022. Historical Cash Flow Quality Index for Access Bio Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Access Bio Inc to assess how comfortably operating cash covers total debt obligations.
Access Bio Inc Cash Flow Quality Index by Year (2012–2022)
Access Bio Inc cash flow quality index by year from 2012 to 2022. Year-by-year earnings quality comparison for Access Bio Inc. For the full cash flow conversion analysis, see 950130 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | ₩291.33 Million | ₩346.67 Billion | ▲ +15.6% |
| 2021 | 0.00x | ₩137.90 Million | ₩189.69 Billion | ▼ -99.9% |
| 2020 | 0.76x | ₩36.72 Billion | ₩48.27 Billion | ▼ -66.4% |
| 2015 | 2.26x | ₩2.87 Billion | ₩1.27 Billion | ▲ +309.1% |
| 2014 | -1.08x | ₩-2.63 Billion | ₩2.43 Billion | ▼ -634.9% |
| 2013 | 0.20x | ₩1.59 Billion | ₩7.84 Billion | ▼ -18.3% |
| 2012 | 0.25x | ₩1.85 Billion | ₩7.45 Billion | — |